EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Adicet Bio's Enterprise Value is €-98.08 Mil.
Adicet Bio's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was €-88.03 Mil. Therefore, Adicet Bio's EV-to-FCF for today is 1.11.
The historical rank and industry rank for Adicet Bio's EV-to-FCF or its related term are showing as below:
STU:1IJA'
s EV-to-FCF Range Over the Past 10 Years
Min: -14.93 Med: -1.51 Max: 3.02
Current: 1.11
During the past 6 years, the highest EV-to-FCF of Adicet Bio was 3.02. The lowest was -14.93. And the median was -1.51.
STU:1IJA's EV-to-FCF is ranked better than 63.35% of 382
companies
in the Biotechnology industry
Industry Median: 7.97
vs STU:1IJA: 1.11
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-05-31), Adicet Bio's stock price is €1.357.
Adicet Bio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €-2.725. Therefore, Adicet Bio's PE Ratio for today is At Loss.
Adicet Bio EV-to-FCF Historical Data
The historical data trend for Adicet Bio's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Adicet Bio's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adicet Bio's EV-to-FCF Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Adicet Bio's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Adicet Bio's EV-to-FCF falls into.
Adicet Bio EV-to-FCF Calculation
Adicet Bio's EV-to-FCF for today is calculated as:
Adicet Bio's current Enterprise Value is €-98.08 Mil.
Adicet Bio's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-88.03 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adicet Bio (STU:1IJA) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Adicet Bio's share price for today is €1.357.
Adicet Bio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.725.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Adicet Bio EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Adicet Bio's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. The company is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. The company operates and manages its business as one reportable and operating segment, which is the business of research and development of allogeneic immunotherapies for cancer and other diseases.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:1IJA has been successfully added to your 